AUTOMA+ 2026

The Pharmaceutical Automation and Digitalisation Congress (AUTOMA+)  2026 is a closed-door event that focuses on the end-to-end digital transformation - from R&D and laboratory automation to manufacturing, packaging, supply chain, compliance and commercial operations. Hosted in Zurich on 16-17 November 2026, the Congress addresses the real constraints shaping digital transformation in pharma - from data integrity and validation to scalability and return on investment.

More than 50 speakers contribute to the agenda, covering: 

• Pharma 4.0 with AI and advanced analytics; 
• R&D and laboratory automation; 
• next-generation digital solutions for GxP compliance;
• quality management and modification of pharma logistics;
• patient-centric digital commercial and marketing strategies; 
• real-world data applications and others.

AUTOMA+ 2026 features perspectives from GSK, Takeda, Novartis, Roche, Johnson & Johnson, SCARLETRED Holding GmbH, WHO and others, reflecting a cross-section of pharmaceutical manufacturing, research, public health and technology expertise. With its focus on applied use cases, AUTOMA+ 2026  demonstrates the practical implementation of automation and digitalisation across regulated pharmaceutical environments today.